Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1999 Apr;64(4):1045–1055. doi: 10.1086/302310

The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother.

D C Shields 1, P N Kirke 1, J L Mills 1, D Ramsbottom 1, A M Molloy 1, H Burke 1, D G Weir 1, J M Scott 1, A S Whitehead 1
PMCID: PMC1377828  PMID: 10090889

Abstract

Recent reports have implicated the "thermolabile" (T) variant of methylenetetrahydrofolate reductase (MTHFR) in the causation of folate-dependent neural tube defects (NTDs). We report herein the largest genetic study of NTD cases (n=271) and families (n=218) to date, establishing that, in Ireland, the "TT" genotype is found in 18.8% of cases versus 8.3% of controls (odds ratio 2.57; confidence interval [CI] 1.48-4.45; P=.0005). The maternal and paternal TT genotypes have intermediate frequencies of 13.8% and 11.9%, respectively, indicating that the predominant MTHFR-related genetic effect acts via the TT genotype of the developing embryo. Analysis of the 218 family triads of mother, father, and affected child with log-linear models supports this interpretation, providing significant evidence that the case TT genotype is associated with NTDs (P=.02) but no evidence of a maternal TT genotypic effect (P=. 83). The log-linear model predicted that the risk of NTDs conferred by the case TT genotype is 1.61 (CI 1.06-2.46), consistent with the paramount importance of the case TT genotype in determining risk. There is no compelling evidence for more than a modest additional risk conferred by a maternal TT genotype. These results favor a biological model of MTHFR-related NTD pathogenesis in which suboptimal maternal folate status imposes biochemical stress on the developing embryo, a stress it is ill-equipped to tolerate if it has a TT genotype.

Full Text

The Full Text of this article is available as a PDF (262.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Czeizel A. E., Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992 Dec 24;327(26):1832–1835. doi: 10.1056/NEJM199212243272602. [DOI] [PubMed] [Google Scholar]
  2. Daly L. E., Kirke P. N., Molloy A., Weir D. G., Scott J. M. Folate levels and neural tube defects. Implications for prevention. JAMA. 1995 Dec 6;274(21):1698–1702. doi: 10.1001/jama.1995.03530210052030. [DOI] [PubMed] [Google Scholar]
  3. Engbersen A. M., Franken D. G., Boers G. H., Stevens E. M., Trijbels F. J., Blom H. J. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet. 1995 Jan;56(1):142–150. [PMC free article] [PubMed] [Google Scholar]
  4. Frosst P., Blom H. J., Milos R., Goyette P., Sheppard C. A., Matthews R. G., Boers G. J., den Heijer M., Kluijtmans L. A., van den Heuvel L. P. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995 May;10(1):111–113. doi: 10.1038/ng0595-111. [DOI] [PubMed] [Google Scholar]
  5. Goyette P., Sumner J. S., Milos R., Duncan A. M., Rosenblatt D. S., Matthews R. G., Rozen R. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet. 1994 Jun;7(2):195–200. doi: 10.1038/ng0694-195. [DOI] [PubMed] [Google Scholar]
  6. Harmon D. L., Woodside J. V., Yarnell J. W., McMaster D., Young I. S., McCrum E. E., Gey K. F., Whitehead A. S., Evans A. E. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM. 1996 Aug;89(8):571–577. doi: 10.1093/qjmed/89.8.571. [DOI] [PubMed] [Google Scholar]
  7. Jacques P. F., Bostom A. G., Williams R. R., Ellison R. C., Eckfeldt J. H., Rosenberg I. H., Selhub J., Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996 Jan 1;93(1):7–9. doi: 10.1161/01.cir.93.1.7. [DOI] [PubMed] [Google Scholar]
  8. Kang S. S., Wong P. W., Zhou J. M., Sora J., Lessick M., Ruggie N., Grcevich G. Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. Metabolism. 1988 Jul;37(7):611–613. doi: 10.1016/0026-0495(88)90076-5. [DOI] [PubMed] [Google Scholar]
  9. Kirke P. N., Molloy A. M., Daly L. E., Burke H., Weir D. G., Scott J. M. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med. 1993 Nov;86(11):703–708. [PubMed] [Google Scholar]
  10. Koch M. C., Stegmann K., Ziegler A., Schröter B., Ermert A. Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population. Eur J Pediatr. 1998 Jun;157(6):487–492. doi: 10.1007/s004310050860. [DOI] [PubMed] [Google Scholar]
  11. Mills J. L., McPartlin J. M., Kirke P. N., Lee Y. J., Conley M. R., Weir D. G., Scott J. M. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet. 1995 Jan 21;345(8943):149–151. doi: 10.1016/s0140-6736(95)90165-5. [DOI] [PubMed] [Google Scholar]
  12. Mitchell L. E. Differentiating between fetal and maternal genotypic effects, using the transmission test for linkage disequilibrium. Am J Hum Genet. 1997 Apr;60(4):1006–1007. [PMC free article] [PubMed] [Google Scholar]
  13. Molloy A. M., Daly S., Mills J. L., Kirke P. N., Whitehead A. S., Ramsbottom D., Conley M. R., Weir D. G., Scott J. M. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet. 1997 May 31;349(9065):1591–1593. doi: 10.1016/S0140-6736(96)12049-3. [DOI] [PubMed] [Google Scholar]
  14. Molloy A. M., Mills J. L., Kirke P. N., Ramsbottom D., McPartlin J. M., Burke H., Conley M., Whitehead A. S., Weir D. G., Scott J. M. Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: low folate status alone may be the critical factor. Am J Med Genet. 1998 Jun 30;78(2):155–159. [PubMed] [Google Scholar]
  15. Mornet E., Muller F., Lenvoisé-Furet A., Delezoide A. L., Col J. Y., Simon-Bouy B., Serre J. L. Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet. 1997 Oct;100(5-6):512–514. doi: 10.1007/s004390050544. [DOI] [PubMed] [Google Scholar]
  16. Morrison K., Edwards Y. H., Lynch S. A., Burn J., Hol F., Mariman E. Methionine synthase and neural tube defects. J Med Genet. 1997 Nov;34(11):958–958. doi: 10.1136/jmg.34.11.958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ou C. Y., Stevenson R. E., Brown V. K., Schwartz C. E., Allen W. P., Khoury M. J., Rozen R., Oakley G. P., Jr, Adams M. J., Jr 5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet. 1996 Jun 28;63(4):610–614. doi: 10.1002/(SICI)1096-8628(19960628)63:4<610::AID-AJMG15>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  18. Papapetrou C., Lynch S. A., Burn J., Edwards Y. H. Methylenetetrahydrofolate reductase and neural tube defects. Lancet. 1996 Jul 6;348(9019):58–58. doi: 10.1016/s0140-6736(05)64382-6. [DOI] [PubMed] [Google Scholar]
  19. Ramsbottom D., Scott J. M., Molloy A., Weir D. G., Kirke P. N., Mills J. L., Gallagher P. M., Whitehead A. S. Are common mutations of cystathionine beta-synthase involved in the aetiology of neural tube defects? Clin Genet. 1997 Jan;51(1):39–42. doi: 10.1111/j.1399-0004.1997.tb02412.x. [DOI] [PubMed] [Google Scholar]
  20. Rosenquist T. H., Ratashak S. A., Selhub J. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15227–15232. doi: 10.1073/pnas.93.26.15227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schaid D. J. General score tests for associations of genetic markers with disease using cases and their parents. Genet Epidemiol. 1996;13(5):423–449. doi: 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  22. Schaid D. J., Sommer S. S. Comparison of statistics for candidate-gene association studies using cases and parents. Am J Hum Genet. 1994 Aug;55(2):402–409. [PMC free article] [PubMed] [Google Scholar]
  23. Scott J., Weir D. Folate/vitamin B12 inter-relationships. Essays Biochem. 1994;28:63–72. [PubMed] [Google Scholar]
  24. Speer M. C., Worley G., Mackey J. F., Melvin E., Oakes W. J., George T. M. The thermolabile variant of methylenetetrahydrofolate reductase (MTHFR) is not a major risk factor for neural tube defect in American Caucasians. The NTD Collaborative Group. Neurogenetics. 1997 Sep;1(2):149–150. doi: 10.1007/s100480050022. [DOI] [PubMed] [Google Scholar]
  25. Spielman R. S., McGinnis R. E., Ewens W. J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993 Mar;52(3):506–516. [PMC free article] [PubMed] [Google Scholar]
  26. States B., Segal S. Levels of gamma-glutamyltranspeptidase in cultured skin fibroblasts from cystinotics and normals. Life Sci. 1980 Nov 24;27(21):1985–1990. doi: 10.1016/0024-3205(80)90419-1. [DOI] [PubMed] [Google Scholar]
  27. Steegers-Theunissen R. P., Boers G. H., Trijbels F. J., Eskes T. K. Neural-tube defects and derangement of homocysteine metabolism. N Engl J Med. 1991 Jan 17;324(3):199–200. doi: 10.1056/NEJM199101173240315. [DOI] [PubMed] [Google Scholar]
  28. Steegers-Theunissen R. P., Boers G. H., Trijbels F. J., Finkelstein J. D., Blom H. J., Thomas C. M., Borm G. F., Wouters M. G., Eskes T. K. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism. 1994 Dec;43(12):1475–1480. doi: 10.1016/0026-0495(94)90004-3. [DOI] [PubMed] [Google Scholar]
  29. Weinberg C. R., Wilcox A. J., Lie R. T. A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting. Am J Hum Genet. 1998 Apr;62(4):969–978. doi: 10.1086/301802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Whitehead A. S., Gallagher P., Mills J. L., Kirke P. N., Burke H., Molloy A. M., Weir D. G., Shields D. C., Scott J. M. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM. 1995 Nov;88(11):763–766. [PubMed] [Google Scholar]
  31. Wilcken D. E., Wang X. L. Relevance to spina bifida of mutated methylenetetrahydrofolate reductase. Lancet. 1996 Feb 3;347(8997):340–340. doi: 10.1016/s0140-6736(96)90526-7. [DOI] [PubMed] [Google Scholar]
  32. de Franchis R., Sebastio G., Mandato C., Andria G., Mastroiacovo P. Spina bifida, 677T-->C mutation, and role of folate. Lancet. 1995 Dec 23;346(8991-8992):1703–1703. doi: 10.1016/s0140-6736(95)92865-0. [DOI] [PubMed] [Google Scholar]
  33. van der Put N. M., Eskes T. K., Blom H. J. Is the common 677C-->T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. QJM. 1997 Feb;90(2):111–115. doi: 10.1093/qjmed/90.2.111. [DOI] [PubMed] [Google Scholar]
  34. van der Put N. M., Steegers-Theunissen R. P., Frosst P., Trijbels F. J., Eskes T. K., van den Heuvel L. P., Mariman E. C., den Heyer M., Rozen R., Blom H. J. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 1995 Oct 21;346(8982):1070–1071. doi: 10.1016/s0140-6736(95)91743-8. [DOI] [PubMed] [Google Scholar]
  35. van der Put N. M., van den Heuvel L. P., Steegers-Theunissen R. P., Trijbels F. J., Eskes T. K., Mariman E. C., den Heyer M., Blom H. J. Decreased methylene tetrahydrofolate reductase activity due to the 677C-->T mutation in families with spina bifida offspring. J Mol Med (Berl) 1996 Nov;74(11):691–694. doi: 10.1007/s001090050073. [DOI] [PubMed] [Google Scholar]
  36. van der Put N. M., van der Molen E. F., Kluijtmans L. A., Heil S. G., Trijbels J. M., Eskes T. K., Van Oppenraaij-Emmerzaal D., Banerjee R., Blom H. J. Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. QJM. 1997 Aug;90(8):511–517. doi: 10.1093/qjmed/90.8.511. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES